Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nrc Health (NRC) Notes Payables (2016 - 2026)

Nrc Health's Notes Payables history spans 16 years, with the latest figure at $4.0 million for Q4 2025.

  • On a quarterly basis, Notes Payables fell 16.18% to $4.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 million, a 16.18% decrease, with the full-year FY2025 number at $4.0 million, down 16.18% from a year prior.
  • Notes Payables hit $4.0 million in Q4 2025 for Nrc Health, roughly flat from $4.0 million in the prior quarter.
  • Over the last five years, Notes Payables for NRC hit a ceiling of $7.6 million in Q2 2024 and a floor of $3.0 million in Q1 2025.
  • Historically, Notes Payables has averaged $4.7 million across 5 years, with a median of $4.4 million in 2022.
  • Biggest five-year swings in Notes Payables: skyrocketed 65.07% in 2024 and later tumbled 59.54% in 2025.
  • Tracing NRC's Notes Payables over 5 years: stood at $4.3 million in 2021, then increased by 4.98% to $4.5 million in 2022, then skyrocketed by 60.63% to $7.2 million in 2023, then plummeted by 33.62% to $4.8 million in 2024, then decreased by 16.18% to $4.0 million in 2025.
  • Business Quant data shows Notes Payables for NRC at $4.0 million in Q4 2025, $4.0 million in Q3 2025, and $3.9 million in Q2 2025.